88636125 - AC IMMUNE

Information

• Trademark
• 88636125

• Source

• Serial Number

  88636125

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 30, 2019
  6 years ago

• Transaction Date

  July 02, 2025
  8 months ago

• Status Date

  July 01, 2025
  8 months ago

• Published for Opposition Date

  May 06, 2025
  10 months ago

• Location Date

  July 01, 2025
  8 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  DETMER, CAROLYN

• Attorney Docket Number

  029140-1

  Attorney Name

  Kristina Montanaro Schrader

  Law Office Assigned Location Code

  N90

• Owners

  • AC IMMUNE SA

Case File Statements

• GS0051: Pharmaceuticals, medical and veterinary preparations for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; diagnostic preparations and materials for medical or veterinary purposes; companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds, all for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; chemico-pharmaceutical preparation for medical purposes, namely, for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; antibodies, antibody fragments and antibody derivatives for use in disease testing, diagnosis, prevention and treatment for medical purposes; pharmaceutical and medical preparations in the nature of small molecule compounds for medical purposes; PET-Imaging compounds in the nature of diagnostic radiopharmaceutical agents for use in PET imaging; diagnostic preparations in the nature of companion compounds for medical use; pharmaceutical and medical preparations in the nature of biomarkers for medical purposes; vaccines; antigenic peptides for the diagnosis, prevention and treatment of neurodegenerative diseases and inflammatory diseases; pharmaceutical and medical preparations in the nature of protein or protein fragments for medical purposes; diagnostic reagents for medical purposes; diagnostic antibodies for medical purposes; none of the aforesaid goods relating to development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases
• GS0011: Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements, namely, chemical preparations for industrial and scientific purposes, other than for medical or veterinary use; chemical, biochemical, biological and biotechnological preparations for use in industry and science; protein, protein fragments, amino acids, antibodies and fragments thereof for industrial, scientific or research purposes, other than for medical or veterinary use; chemical preparations comprising small molecules for use in industry and science; molecular libraries, comprising libraries of chemical preparations for use in industry and science; small molecule library, comprising libraries of chemical preparations for use in industry and science; antibody library, comprising libraries of antibodies for scientific or research use; reagents for use in the development of antibodies, proteins for binding or detecting antibodies and antibody-producing hybridoma cells for scientific or research purposes or for industrial use; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; biological cell, biological tissue culture for use in non-medical research laboratories; diagnostic tools in the nature of preparations, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use; none of the aforesaid goods relating to development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases
• DS0000: "IMMUNE"
• GS0421: Scientific and technological services, namely, scientific research, analysis and testing and the development of technology in the field of medicine and pharmaceuticals and research activities relating thereto; providing access to a proprietary technology platform containing antibodies, vaccines and small molecules that gives users the ability to obtain information for research purposes; biological research services; chemical research services in the fields of neurodegenerative diseases and inflammatory diseases; medical research services; scientific and medical laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, antibodies, vaccines and test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; biological research, namely, screening and selection of pharmaceutical active substances from biological and biotechnological preparations; custom design and development of biological assays; research and development, namely, vaccine and antibody engineering; none of the aforesaid services relating to development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases

Case File Event Statements

• 10/3/2019 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/3/2019 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/3/2020 - 6 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/7/2020 - 6 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/7/2020 - 6 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/7/2020 - 6 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/2/2020 - 5 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/2/2020 - 5 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/3/2020 - 5 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/29/2020 - 5 years ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 7/29/2020 - 5 years ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 7/29/2020 - 5 years ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 7/6/2021 - 4 years ago

  13 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 8/10/2021 - 4 years ago

  14 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 8/10/2021 - 4 years ago

  15 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 8/10/2021 - 4 years ago

  16 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 1/27/2022 - 4 years ago

  17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/27/2022 - 4 years ago

  18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/27/2022 - 4 years ago

  19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/27/2022 - 4 years ago

  20 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 1/31/2022 - 4 years ago

  21 - ASSIGNED TO LIE Type: ALIE

• 2/9/2022 - 4 years ago

  22 - ASSIGNED TO LIE Type: ALIE

• 2/14/2022 - 4 years ago

  23 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/14/2022 - 4 years ago

  24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/14/2022 - 4 years ago

  25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/27/2022 - 3 years ago

  26 - SUSPENSION LETTER WRITTEN Type: CNSL

• 4/27/2022 - 3 years ago

  27 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 4/27/2022 - 3 years ago

  28 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 11/30/2022 - 3 years ago

  29 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 12/4/2023 - 2 years ago

  30 - ASSIGNED TO EXAMINER Type: DOCK

• 12/6/2023 - 2 years ago

  31 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 2/28/2024 - 2 years ago

  32 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 2/28/2024 - 2 years ago

  33 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 2/28/2024 - 2 years ago

  34 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 5/16/2024 - a year ago

  35 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 6/18/2024 - a year ago

  38 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/19/2024 - a year ago

  39 - SUSPENSION LETTER WRITTEN Type: CNSL

• 6/19/2024 - a year ago

  40 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 6/19/2024 - a year ago

  41 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/18/2024 - a year ago

  37 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/18/2024 - a year ago

  36 - ASSIGNED TO LIE Type: ALIE

• 12/23/2024 - a year ago

  44 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/23/2024 - a year ago

  43 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/23/2024 - a year ago

  42 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 1/6/2025 - a year ago

  45 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 1/6/2025 - a year ago

  46 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 1/6/2025 - a year ago

  47 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 4/7/2025 - 11 months ago

  49 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/7/2025 - 11 months ago

  48 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/7/2025 - 11 months ago

  50 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/8/2025 - 11 months ago

  51 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/30/2025 - 10 months ago

  52 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/6/2025 - 10 months ago

  53 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/6/2025 - 10 months ago

  54 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/1/2025 - 8 months ago

  55 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM